Revised 8.27.2014 Italics are instructions.WIRB/UCD Consent and HIPAA Authorization Form Template with ChecklistFor WIRB protocol submissions, please submit the sponsor's consent form and this template/checklist only.  No other consent form is needed.  Once this paperwork is received at WIRB, the standard required UCD and WIRB language will be incorporated into the consent.  Please note however, that you must choose the appropriate wording in the Procedures, Benefits, Alternative Treatments, Cost, and Injury and Compensation sections Must choose one only:Benefits Subject PaymentCost Injury and Compensation Additional wording if applicable to the study is available on COMIRB website:Discomforts and RisksData and specimen banking for future researchRequired Children's Hospital Colorado Additional Consent LanguageNOTE:  University of Colorado - Denver has now incorporated HIPAA B language into the WIRB/UCD Consent Form Template.  The stand-alone HIPAA A form will still continue to be used for recruitment.
RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORMTITLE:	[Title as written on the first page of protocol]PROTOCOL NO.:	[Sponsor protocol number]	WIRB(r) Protocol # [to be added by WIRB]	IRB ##-####SPONSOR:	[Sponsor Name]INVESTIGATOR:	[Name]	[Address]	[City, State, Zip Code]	[Country]STUDY-RELATED PHONE NUMBER(S):	[Contact name with degree]	[Telephone number]	[24 hour telephone number, if available]This consent form may contain words that you do not understand.  Please ask the study doctor or the study staff to explain any words or information that you do not clearly understand.  You may take home an unsigned copy of this consent form to think about or discuss with family or friends before making your decision.Why is this study being done?This study plans to learn more about . . . .ANDYou are being asked to be in this research study because . . . Other people in this studyUp to ___________ people from your area will participate in the study.Up to ___________ people around the country will be in the study.  WIRB requires that drugs which are not approved for the use being studied, be identified as "investigational" and the following statement must be included:  "Investigational" means that the study drug has not been approved by the U.S. Food and Drug Administration (FDA).What happens if I join this study?  If you join the study, you will...What are the possible discomforts or risks?For all applicable studies include: The study may include risks that are unknown at this time.WIRB requirement - if study drug is taken homeOnly you can take the study drug.  It must be kept out of the reach of children and persons who may not be able to read or understand the label.Pregnancy language, for example:  Women who are pregnant or nursing a child may not participate in this study.  You must confirm that, to the best of your knowledge, you are not now pregnant, and that you do not intend to become pregnant during the study.  Before entering the study, you and the study doctor must agree on the method of birth control you will use during the entire study.  If you suspect that you have become pregnant during the study, you must notify the study doctor immediately.  Pregnant women will be withdrawn from the study because the risks to the unborn fetus from the study drug are not known.[or other pregnancy language supplied by sponsor]What are the possible benefits of the study?  CHOOSE ONE:Some medical benefit to subject:This study is designed for the researcher to learn more about <disease or condition> or <the effects of the study drug/device> on your <disease or condition>.ORNo medical benefit to subject:This study was not designed to treat any illness or to improve your health.  Also, there could be risks to being in this study.Are there alternative treatments?There may be other ways of treating your < list disease or medical problem here >.  These other ways include < list alternative treatments, or delete sentence if none >.  [You could also choose to get no treatment at all - if relevant.]You should talk to your doctor about your choices.  Make sure you understand all of your choices before you decide to take part in this study.  You may leave this study and still have these other choices available to you.ONCOLOGY STUDY ONLY:There may be other treatments for your cancer.There may be other ways of treating your <list disease or medical problem here>.  These other ways include <list accepted alternative treatments, you may include other investigational treatment, but not specific studies>.You have the following choices available to you: Get any of the cancer treatments listed above, together with a treatment for your pain and symptoms. Get treatment only for your pain and symptoms, but no treatment for the cancer itself. Get no treatment at all.You should talk to your doctor about your choices.  Make sure that you understand all of your choices before you decide to take part in the study.  You may leave this study and still have these other choices available to you.Who is sponsoring this study?This research is being paid for by <sponsor>, the manufacturer of the study <drug/device>.Will I be paid for being in this study?Choose statement that applies:You will be paid $XX.XX for each study visits that you complete.  <(if the amount will vary from visit to visit, state the different amounts and visit types>.  This will add up to a total of $XXX.XX if you complete all of the study visits <if some subjects may get a particular procedure while others may not, break this into different amounts and explain>.  If you leave the study early, or if we have to take you out of the study, you will be paid only for the visits you have completed.Payment for participation in a study is taxable income.ORYou will not be paid to be in the study.Will I have to pay for anything?Choose statement that applies:You will need to pay for...ORYou will not be charged for the study drug/device or any of the study procedures or office visits.For oncology studies:The study sponsor, <sponsor name>, will pay for the cost of the study drug.  The sponsor will also pay for any tests or procedures that are related to the research study.You will need to pay for any tests and procedures that are considered standard of care.  These include the CT scans, MRI's and some clinic visits and laboratory tests.  You may be responsible for co-payments and deductibles that are standard for your insurance coverage.Ask your study doctor to discuss the costs that will or will not be covered by the sponsor.  This discussion should include the costs of treating possible side effects.  Otherwise, you might have unexpected expenses from being in this study.Is my participation voluntary?Taking part in this study is voluntary.  You have the right to choose not to take part in this study.  If you choose to take part, you have the right to stop at any time.  If you refuse or decide to withdraw later, you will not lose any benefits or rights to which you are entitled.If this is applicable, state: If you leave this study, you will still receive your normal medical care.  The only medical care that you will lose is the medical care you are getting as part of this study.  You might be able to get that same kind of medical care outside of the study.  Ask your study doctor. If this is applicable, state:  You will be told if there are any new findings during the study that may affect whether you want to continue to take part.Can I be removed from this study? [If applicable]The study doctor may decide to stop your participation without your permission if the study doctor thinks that being in the study may cause you harm, or for any other reason.  Also, the sponsor may stop the study at any time.What happens if I am injured or hurt during the study?  (include section, if applicable)[Plans for injury and compensation must be included for research involving more than minimal risk If applicable, state:  If you have an injury while you are in this study, you should call <insert name> immediately.  [His/her] phone number is <insert phone number>.1.	We will arrange to get you medical care if you have an injury that is caused by this research.  However, you or your insurance company will have to pay for that care.OR2.	If you are hurt by this research, we will give you medical care.  Medical treatment will be provided at no cost to you or your insurance company for a research-related injury.  The sponsor and the investigator will determine if your injury or illness is research-related.  The term "research-related injury" means physical injury caused by drugs or procedures required by the study which are different from the medical treatment you would have received if you had not participated in the trial.[PLEASE NOTE:  The study sponsor may negotiate different language for this section for some trials.  The wording that is submitted with the consent draft should remain 'AS IS' as long as this change in wording is accompanied by approval email from UCD]Who do I call if I have questions?Contact 	[name]	 at 	[number(s)]	 for any of the following reasons: if you have any questions about your participation in this study,   if at any time you feel you have had a research-related injury or a reaction to the study drug, or if you have questions, concerns or complaints about the researchIf you have questions about your rights as a research subject or if you have questions, concerns or complaints about the research, you may contact:	Western Institutional Review Board(r) (WIRB(r))	1019 39th Avenue SE Suite 120	Puyallup, Washington  98374-2115	Telephone:  1-800-562-4789 or 360-252-2500	E-mail: Help@wirb.com.OR      Colorado Multiple Institutional Review Board (COMIRB) office at 303-724-1055WIRB is a group of people who perform independent review of research under contract with the University of Colorado Denver.WIRB will not be able to answer some study-specific questions, such as questions about appointment times.  However, you may contact WIRB if the research staff cannot be reached or if you wish to talk to someone other than the research staff.Do not sign this consent form unless you have had a chance to ask questions and have received satisfactory answers to all of your questions.Who will see my research information?The University of Colorado Denver and the hospital(s) it works with have rules to protect information about you.  Federal and state laws including the Health Insurance Portability and Accountability Act (HIPAA) also protect your privacy.  This part of the consent form tells you what information about you may be collected in this study and who might see or use it.  The institutions involved in this study include: (delete those that do not apply for this study) University of Colorado Denver University of Colorado Hospital Children's Hospital Colorado Denver Health and Hospital Authority Other (name; use this space for other affiliated institutions only, such as Barbara Davis Center, etc.)Both the records that identify you and the consent form signed by you may be looked at by others who have a legal right to see that information.* Federal offices such as the Office of Human Research Protection and the Food and Drug Administration (FDA) that protect research subjects like you.* People at the Colorado Multiple Institutional Review Board (COMIRB)* People at the Western Institutional Review Board (WIRB)* The study doctor and his/her team of researchers.* <insert sponsor name>, who is the company paying for this research study.* Officials at <the institution where the research is being conducted> and officials at other institutions involved in this study who are in charge of making sure that we follow all of the rules for research* <add any other groups or entities that are applicable>Your information may be used and disclosed, to do the research, to study the results, and to make sure that the research was done right.We might talk about this research study at meetings.  We might also print the results of this research study in relevant journals.  But we will always keep the names of the research subjects, like you, private.A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. Law.  This Web site will not include information that can identify you.  At most, the Web site will include a summary of the results.  You can search this Web site at any time.You have the right to request access to your personal health information from the investigator.  [Include only if applicable To ensure proper evaluation of test results, your access to these study results may not be allowed until after the study has been completed.We cannot do this study without your permission to see, use and give out your information.  You do not have to give us this permission.  If you do not, then you may not join this study.We will see, use and disclose your information only as described in this form and in our Notice of Privacy Practices; however, people outside the University of Colorado Denver and its affiliate hospitals may not be covered by this promise and your information may be disclosed without your permission.We will do everything we can to keep your records confidential. It cannot be guaranteed.The use and disclosure of your information has no time limit.  You can cancel your permission to use and disclose your information at any time by writing to the study's Principal Investigator, at the name and address listed below.  If you do cancel your permission to use and disclose your information, your part in this study will end and no further information about you will be collected.  Your cancellation would not affect information already collected in this study.  	PI Name and Mailing AddressIf you agree to be in this study, you will receive a signed and dated copy of this consent form for your records.[This section is for outside disclosures of research information that you will make. Name of specific study-related person or group, external to UCD, such as the Sponsor, specific lab or Contract Research Organization (CRO). If no outside disclosures of data, delete]The investigator (or staff acting on behalf of the investigator) will use your information for the research outlined in this consent form. They will also make all or some of the following health information about you collected in this study available to :  _____________________________________________ [if applicable]  Some of the research procedures involve genetic testing or the use of your genetic information.  Your genetic information [choose one] will not be released to others or    will be released to: _____________________Information about you that will be seen, collected, used and disclosed in this study:(delete all that do not apply) Name and Demographic Information (age, sex, ethnicity, address, phone number, etc. Your social security number Portions of my previous and current Medical Records that are relevant to this study, including but not limited to Diagnosis(es), History and Physical, laboratory or tissue studies, radiology studies, procedure results Research Visit and Research Test records Psychological tests Alcoholism, Alcohol or Drug abuse Testing for infection with diseases reportable to the Public Health department, including but not limited to: Human Immunodeficiency Virus (HIV), hepatitis (all forms) tuberculosis, or other sexually transmitted diseases. Testing for sickle cell Tissue samples and the data with the samples.  Billing or financial information Other (please specify): _____________________________________________What happens to Data, Tissue, Blood and Specimens that are collected in this study? (delete types of data that do not apply, in header and in the following text)Scientists at the University of Colorado Denver and the hospitals involved in this study work to find the causes and cures of disease.  The data, tissue, blood and specimens collected from you during this study are important to this study and to future research.  If you join this study:* The data, or the tissue, blood, or other specimens are given by you to the investigators for this research and so no longer belong to you.* Both the investigators and any sponsor of this research may study your data and tissue, blood, or other specimens collected from you.* If data, tissue, blood, or other specimens are in a form that identifies you, UCD or the hospitals involved in this study may use them for future research only with your consent or IRB approval.* Any product or idea created by the researchers working on this study will not belong to you.* There is no plan for you to receive any financial benefit from the creation, use or sale of such a product or idea. The University of Colorado Denver has standardized language for tissue banking or storage of samples for future use which can be found on the COMIRB website. [If there are no optional procedures in this study or the optional procedures are in the addendum consent form, delete the HIPAA Authorization for Optional Additional Study Procedures below]HIPAA Authorization for Optional Additional Study Procedures - [if applicable]In this form, you were given the option to agree to additional, optional research procedures.  You must also give us your permission, under HIPAA rules, to use and disclose the information collected from these optional procedures, as described above.  [if applicable]  Some of these optional procedures may involve genetic testing or the use of your genetic information.  Your genetic information [choose one] will not be released to you or others or   will be released to: _____________________If you decline to give us permission to use and disclose your information, you cannot take part in these optional procedures, but you can still participate in the main study.  Please initial next to your choice:_____ I give permission for my information, from the optional procedures I have agreed to above, to be used and disclosed as described in this section._____ I do not give permission for my information for any optional procedures to be used and disclosed; I understand that I will not participate in any optional procedures.Agreement to be in this study and use my data:I have read this paper about the study or it was read to me.  I understand the possible risks and benefits of this study as described in this form.  I understand and authorize the access, use and disclosure of my information as stated in this form.  I know that being in this study is voluntary.  I choose to be in this study: I will get a signed and dated copy of this consent form.[Add additional standardized language as necessary to the research.]Signature:									Date:			Print Name:								Consent form explained by:							Date:			Print Name:								Investigator: _______________________________				Date: _______		            Investigator must sign within ___[maximum 30] daysThe investigator signature line is required for FDA-regulated research, but also may be required by the reviewing IRB panel. The purpose of this line is to document that the PI reviewed the qualifications of the subject to be in this study. The IRB may require this signature line if the inclusion/exclusion criteria are complex, or if the study poses significant risks to subjects. If you are including this signature line (or if required by the IRB), please enter the number of days within which the PI will sign the form. The PI should sign the form in an appropriate amount of time to receive the necessary screening results to determine subject eligibility, but before the subject begins study procedures (maximum 30 days).[If requested, add Signature Line for witness; required for consent of non-reading subjects and consent using a short form, if you requested such consent procedures______________________________________________	  		Date________	_	Signature of witnessPrint Name (witness):						Witness of Signature			Witness of consent process	[If Applicable, Signature Line For Studies with an LAR or Proxy Decision Maker]______________________________________________	  		Date_________	Legally Authorized Representative/ Proxy Decision MakerPrint Name:								[If Applicable, Signature Boxes for studies with children ages 13-18 who can read this form. Children 7-13 should sign a SEPARATE assent form, which is a separate document with separately numbered pages; for children 0-7, the parents are consented using this form.Child's Name: ______________________________________________	_________________			First		Middle Initial		Last		       Date of birthFirst Parent/Guardian Consent for Child's Participation:I consent to allow my child to participate in this study.____________________________________________________	_____________1st Parent/Guardian Signature		DatePrint Name: ___________________________________________	_____________Relationship to Participant:     Mother    Father   Guardian 	TimeSecond Parent/Guardian Consent for Child's Participation: (if available)I consent to allow my child to participate in this study.____________________________________________________	_____________2nd Parent/Guardian Signature		DatePrint Name: ___________________________________________	_____________Relationship to Participant:   Mother    Father   Guardian	TimeChild Participant  Ages 13-17 Who Can Read This Consent: I consent to participate in this study____________________________________________________	_____________Child Participant (Age 13-17) Signature		DatePrint Name: ___________________________________________	_____________		TimeAdult Participant (18 years of age or older) or Re-Consent for Self Participation:I consent to participate in this study____________________________________________________	_____________Adult Participant Signature		DatePrint Name: ___________________________________________	_____________		Time Consent form explained byI have given this research subject (or his/her legally authorized representative, if applicable) information about this study that I believe is accurate and complete.  The subject has indicated that he or she understands the nature of the study and the risks and benefits of participating.____________________________________________________	_____________Signature		DateTitle:  Principal Investigator 	 Sub Investigator 	 Research CoordinatorPrint Name: ___________________________________________	_____________		Time Principle Investigator:Investigator must sign within 30 days____________________________________________________	_____________Signature		DateWitness Signature (if applicable)____________________________________________________	_____________  Witness of Signature	  Witness of consent process 	Date[If there are no optional procedures in this study or the optional procedures are in the main consent form, delete the remainder of this form]Additional Optional Study ProceduresThe following are additional optional study procedures that you are being asked to consider.  You may choose to participate in any, or none, of the following procedures.  Your decision to participate, or to not participate, in these additional procedures will not affect your ability to participate in the main study you agreed to above.[Insert description of each optional procedure, with separate header and agree/disagree initial lines, according to the example below. If banking is an optional procedure, it should be included in this section; you may wish to use COMIRB's standard optional banking addendum.]Optional Procedure Header #1[description]Initial next to your choice:_____  I agree to participate in this optional procedure_____  I do not agree to participate in this optional procedureOptional Procedure Header #2[description]Initial next to your choice:_____  I agree to participate in this optional procedure_____  I do not agree to participate in this optional procedureWho will see my research information collected for these additional procedures?The University of Colorado Denver and the hospital(s) it works with have rules to protect information about you.  Federal and state laws including the Health Insurance Portability and Accountability Act (HIPAA) also protect your privacy.   This part of the consent form tells you what information about you may be collected for these additional optional procedures and who might see or use it.  The institutions involved in this study include (delete those that do not apply for this study; these bullets should list only local institutions)* University of Colorado Denver* University of Colorado Hospital* Children's Hospital Colorado* Denver Health and Hospital Authority* Other (name; use this space for other affiliated institutions only, such as Barbara Davis Center, etc.)Both the records that identify you and the consent form signed by you may be looked at by others who have a legal right to see that information.   * Federal offices such as the Office of Human Research Protection and the Food and Drug Administration (FDA) that protect research subjects like you.* People at the Colorado Multiple Institutional Review Board (COMIRB)* People at the Western Institutional Review Board (WIRB)* The study doctor and his/her team of researchers* <insert sponsor name>, who is the company paying for this research study.* Officials at <the institution where the research is being conducted> and officials at other institutions involved in this study who are in charge of making sure that we follow all of the rules for research* <add any other groups or entities that are applicable>Your information may be used and disclosed, to do the research, to study the results, and to make sure that the research was done right.We might talk about this research study at meetings.  We might also print the results of this research study in relevant journals.  But we will always keep the names of the research subjects, like you, private. You have the right to request access to your personal health information from the investigator. [Include only if applicable] To ensure proper evaluation of test results, your access to these study results may not be allowed until after the study is completed.We cannot do these additional procedures without your permission to see, use and give out your information.  You do not have to give us this permission.  If you do not, then you may not take part in these optional procedures.  We will see, use and disclose your information only as described in this form and in our Notice of Privacy Practices; however, people outside the UCD and its affiliate hospitals may not be covered by this obligation.We will do everything we can to keep your records confidential. It cannot be guaranteed. The use and disclosure of your information has no time limit.  You can cancel your permission to use and disclose your information at any time by writing to the study's Principal Investigator (PI), at the name and address listed below.  If you do cancel your permission to use and disclose your information, your part in these optional procedures will end and no further information about you will be collected.  Your cancellation would not affect information already collected from these procedures.  Enter PI Name and Mailing Address .[This section is for outside disclosures of research information that you will make. Name of specific study-related person or group, external to UCD, such as the Sponsor, specific lab or Contract Research Organization (CRO). If no outside disclosures of data, delete]The investigator (or staff acting on behalf of the investigator) will use your information for the research outlined above. They will also make all or some of the following health information about you collected for these additional optional procedures available to:  _____________________________________________ [if applicable]  Some of these optional procedures involve genetic testing or the use of your genetic information.  Your genetic information [choose one] will not be released to others or    will be released to: _____________________ Information about you that will be seen, collected, used and disclosed for these optional procedures:(delete all that do not apply)* Name and Demographic Information (age, sex, ethnicity, address, phone number, etc.* Your social security number* Portions of your previous and current Medical Records that are relevant to this study, including but not limited to Diagnosis(es), History and Physical, laboratory or tissue studies, radiology studies, procedure results* Research Visit and Research Test records* Psychological and mental health tests* Alcoholism, Alcohol or Drug abuse* Testing for or infection with diseases reportable to the Public Health department, including but not limited to: Human Immunodeficiency Virus (HIV), hepatitis (all forms) tuberculosis, or other sexually transmitted diseases.* Testing for sickle cell* Tissue samples and the data with the samples. * Billing or financial information* Other (please specify): _____________________________________________What happens to Data, Tissue, Blood and Specimens that are collected for these additional optional procedures? [delete types of data that do not apply, in header and in the following text]Scientists at the University of Colorado Denver and the hospitals involved in this study work to find the causes and cures of disease.  The data, tissue, blood and specimens collected from you during this study are important to this study and to future research.  If you join this study:* The data, tissue, blood, or other specimens given by you to the investigators for this research no longer belong to you.  * Both the investigators and any sponsor of this research may study your data, tissue, blood, or other specimens collected from you.* If data, tissue, blood, or other specimens are in a form that identifies you, UCD or the hospitals involved in this study may use them for future research only with your consent or Institutional Review Board (IRB) approval.* Any product or idea created by the researchers working on this study will not belong to you.* There is no plan for you to receive any financial benefit from the creation, use or sale of such a product or idea. Agreement to participate in the additional optional procedures and use my dataI have read this paper about the additional optional procedures above or it was read to me.  I have indicated my choice to participate, or to not participate, in each additional procedure above.  I understand the possible risks and benefits of these research procedures.  I understand and authorize the access, use and disclosure of my information as stated in this form.  I know that participation in these additional procedures is voluntary.  I choose to participate in these research procedures as I have indicated above: I will get a signed and dated copy of this consent form.Signature:									Date:				Print Name:								Consent form explained by:							Date:			Print Name:								Investigator: _______________________________				Date: _______		            Investigator must sign within ___[maximum 30] daysThe investigator signature line is required for FDA-regulated research, but also may be required by the reviewing IRB panel. The purpose of this line is to document that the PI reviewed the qualifications of the subject to be in this study. The IRB may require this signature line if the inclusion/exclusion criteria are complex, or if the study poses significant risks to subjects. If you are including this signature line (or if required by the IRB), please enter the number of days within which the PI will sign the form. The PI should sign the form in an appropriate amount of time to receive the necessary screening results to determine subject eligibility, but before the subject begins study procedures (maximum 30 days).[If requested, add Signature Line for witness; required for consent of non-reading subjects and consent using a short form, if you requested such consent procedures______________________________________________	  		Date_________	Signature of witnessPrint Name (witness):						Witness of Signature			Witness of consent process	[If Applicable, Signature Line For Studies with an LAR or Proxy Decision Maker]______________________________________________	  		Date_________	Legally Authorized Representative/ Proxy Decision MakerPrint Name:									[If Applicable, Signature Boxes for optional study procedures with children ages 13-18 who can read this form. Children 7-13 should sign a SEPARATE assent form, which is a separate document with separately numbered pages; for children 0-7, the parents are consented using this form.)Child's Name: ______________________________________________	_________________			First		Middle Initial		Last		       Date of birthFirst Parent/Guardian Consent for Child's Participation:I consent to allow my child to participate in this study.____________________________________________________	_____________1st Parent/Guardian Signature		DatePrint Name: ___________________________________________	_____________Relationship to Participant:     Mother    Father   Guardian 	TimeSecond Parent/Guardian Consent for Child's Participation: (if available)I consent to allow my child to participate in this study.____________________________________________________	_____________2nd Parent/Guardian Signature		DatePrint Name: ___________________________________________	_____________Relationship to Participant:   Mother    Father   Guardian	TimeChild Participant  Ages 13-17 Who Can Read This Consent: I consent to participate in this study____________________________________________________	_____________Child Participant (Age 13-17) Signature		DatePrint Name: ___________________________________________	_____________		TimeAdult Participant (18 years of age or older) or Re-Consent for Self Participation:I consent to participate in this study____________________________________________________	_____________Adult Participant Signature		DatePrint Name: ___________________________________________	_____________		Time Consent form explained byI have given this research subject (or his/her legally authorized representative, if applicable) information about this study that I believe is accurate and complete.  The subject has indicated that he or she understands the nature of the study and the risks and benefits of participating.____________________________________________________	_____________Signature		DateTitle:  Principal Investigator 	 Sub Investigator 	 Research CoordinatorPrint Name: ___________________________________________	_____________		Time Principle Investigator:Investigator must sign within 30 days____________________________________________________	_____________Signature		DateWitness Signature (if applicable)____________________________________________________	_____________  Witness of Signature	  Witness of consent process 	Date	6Page 1 of 3		Subject Initials ________